Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Till Milde

Showing results (51-60 of 161) with videos related to

Pageof 17
Sort By:
Nature Reviews. Cancer|July 14, 2019
Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumoursDavid T W Jones, Ana Banito, Thomas G P Grünewald, et al.
The Journal of Clinical Investigation|September 11, 2013
Retinal angiogenesis suppression through small molecule activation of p53Sai H Chavala, Younghee Kim, Laura Tudisco, et al.
Acta Neuropathologica Communications|April 9, 2015
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastomaJonas Ecker, Ina Oehme, Ralph Mazitschek, et al.
Journal of Neuro-Oncology|November 24, 2023
Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflowFlorian Selt, Ahmed El Damaty, Martin U Schuhmann, et al.
Klinische Padiatrie|July 12, 2018
Molecular Diagnostics in Pediatric Brain Tumors: Impact on Diagnosis and Clinical Decision-Making - A Selected Case SeriesHeidi Bächli, Jonas Ecker, Cornelis van Tilburg, et al.
Cancers|September 10, 2021
Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for NeuroblastomaMichael Müller, Lisa Rösch, Sara Najafi, et al.
Oncotarget|August 25, 2016
Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymomaTheophilos Tzaridis, Till Milde, Kristian W Pajtler, et al.
Acta Neuropathologica Communications|August 21, 2025
Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profilingKonstantin Okonechnikov, David R Ghasemi, Daniel Schrimpf, et al.
Acta Neuropathologica Communications|January 6, 2025
Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profilingKonstantin Okonechnikov, David R Ghasemi, Daniel Schrimpf, et al.
Scientific Reports|April 18, 2025
Association of phosphorylation status of ERK and genetic MAPK alterations in pediatric tumorsFlorian Selt, Romain Sigaud, Andrey Korshunov, et al.
Pageof 17

Showing results (51-60 of 161) with videos related to

Sort By:
Pageof 17
Nature Reviews. Cancer|July 14, 2019
Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumoursDavid T W Jones, Ana Banito, Thomas G P Grünewald, et al.
The Journal of Clinical Investigation|September 11, 2013
Retinal angiogenesis suppression through small molecule activation of p53Sai H Chavala, Younghee Kim, Laura Tudisco, et al.
Acta Neuropathologica Communications|April 9, 2015
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastomaJonas Ecker, Ina Oehme, Ralph Mazitschek, et al.
Journal of Neuro-Oncology|November 24, 2023
Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflowFlorian Selt, Ahmed El Damaty, Martin U Schuhmann, et al.
Klinische Padiatrie|July 12, 2018
Molecular Diagnostics in Pediatric Brain Tumors: Impact on Diagnosis and Clinical Decision-Making - A Selected Case SeriesHeidi Bächli, Jonas Ecker, Cornelis van Tilburg, et al.
Cancers|September 10, 2021
Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for NeuroblastomaMichael Müller, Lisa Rösch, Sara Najafi, et al.
Oncotarget|August 25, 2016
Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymomaTheophilos Tzaridis, Till Milde, Kristian W Pajtler, et al.
Acta Neuropathologica Communications|August 21, 2025
Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profilingKonstantin Okonechnikov, David R Ghasemi, Daniel Schrimpf, et al.
Acta Neuropathologica Communications|January 6, 2025
Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profilingKonstantin Okonechnikov, David R Ghasemi, Daniel Schrimpf, et al.
Scientific Reports|April 18, 2025
Association of phosphorylation status of ERK and genetic MAPK alterations in pediatric tumorsFlorian Selt, Romain Sigaud, Andrey Korshunov, et al.
Pageof 17